Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$10.5B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.45B |
| 3 |
Altria Group
MO
|
+$625M |
| 4 |
Kraft Heinz
KHC
|
+$570M |
| 5 |
Netflix
NFLX
|
+$526M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.44B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$1.29B |
| 3 |
Wells Fargo
WFC
|
+$875M |
| 4 |
Qualcomm
QCOM
|
+$771M |
| 5 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.07% |
| 2 | Financials | 8.9% |
| 3 | Technology | 7.48% |
| 4 | Consumer Discretionary | 7.12% |
| 5 | Communication Services | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gilead Sciences
GILD
$163B
| $883M | 0.33% |
8,997,353
+1,950,391
| +28% | +$217M |
|
52
Williams Companies
WMB
$86.7B
| $871M | 0.32% |
23,641,599
+2,953,889
| +14% | +$147M |
|
53
Accenture
ACN
$99.9B
| $865M | 0.32% |
8,803,083
-701,614
| -7% | -$69.6M |
|
54
ExxonMobil
XOM
$651B
| $841M | 0.31% |
11,316,978
-235,411
| -2% | -$18.1M |
|
|
TWX
55
DELISTED
Time Warner Inc
TWX
| $834M | 0.31% |
12,124,231
+635,845
| +6% | +$49.9M |
|
56
Bristol-Myers Squibb
BMY
$132B
| $811M | 0.3% |
13,703,923
+537,495
| +4% | +$34.1M |
|
57
Blackrock
BLK
$170B
| $810M | 0.3% |
2,722,266
-78,816
| -3% | -$25.4M |
|
58
iShares Biotechnology ETF
IBB
$9.52B
| $791M | 0.29% |
7,818,417
+2,268,657
| +41% | +$272M |
|
59
Comcast
CMCSA
$84B
| $781M | 0.29% |
27,451,584
+8,564,428
| +45% | +$254M |
|
60
Vornado Realty Trust
VNO
$7.55B
| $776M | 0.29% |
10,617,192
-139,583
| -1% | -$10.5M |
|
|
AGN
61
DELISTED
Allergan plc
AGN
| $774M | 0.29% |
2,848,596
-146,661
| -5% | -$45.1M |
|
62
iShares MSCI EAFE ETF
EFA
$78.5B
| $773M | 0.29% |
13,482,013
-2,940,557
| -18% | -$182M |
|
63
SPDR Gold Trust
GLD
$133B
| $773M | 0.29% |
7,230,191
+2,521,993
| +54% | +$272M |
|
64
iShares Russell 1000 Growth ETF
IWF
$120B
| $772M | 0.29% |
33,217,820
+931,340
| +3% | +$22.9M |
|
65
Cencora
COR
$60.7B
| $757M | 0.28% |
7,966,129
+1,708,146
| +27% | +$179M |
|
66
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $746M | 0.28% |
11,987,551
+5,287,126
| +79% | +$417M |
|
67
American Express
AXP
$228B
| $745M | 0.28% |
10,055,529
+254,016
| +3% | +$19.5M |
|
68
Intel
INTC
$460B
| $742M | 0.27% |
24,621,846
+3,845,371
| +19% | +$111M |
|
69
Abbott
ABT
$183B
| $733M | 0.27% |
18,221,726
+2,304,922
| +14% | +$109M |
|
70
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $719M | 0.27% |
21,735,231
-3,472,691
| -14% | -$126M |
|
71
Monster Beverage
MNST
$95.5B
| $713M | 0.26% |
31,665,264
+20,709,486
| +189% | +$485M |
|
72
Intuitive Surgical
ISRG
$126B
| $711M | 0.26% |
13,919,427
-1,835,109
| -12% | -$104M |
|
73
Crown Castle
CCI
$33.4B
| $703M | 0.26% |
8,908,131
+926,427
| +12% | +$75.3M |
|
74
Thermo Fisher Scientific
TMO
$214B
| $702M | 0.26% |
5,743,789
+354,876
| +7% | +$46.2M |
|
75
Zoetis
ZTS
$31.9B
| $698M | 0.26% |
16,961,063
-1,475,750
| -8% | -$68.4M |
|
Similar funds
Morgan Stanley's Q3 2015 Portfolio in Review
As of Q3 2015, Morgan Stanley held 7,097 positions worth $271B, down 6.2% from $289B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley deployed $8.75B of net new capital in Q3 2015, opening 161 new positions and adding to 2,856 existing holdings. Its largest new stake was Kraft Heinz: 7,552,361 shares worth $533M.
By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 11% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was AbbVie, an estimated $1.44B trimmed.
- Morgan Stanley's largest Q3 2015 buy was Kraft Heinz: 7,552,361 shares worth $533M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $10.5B increase.
- Morgan Stanley's biggest Q3 2015 reduction was AbbVie, cutting an estimated $1.44B.
- Morgan Stanley fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $458M.
- Morgan Stanley's ten largest holdings make up 15% of its $271B portfolio in Q3 2015.
- Morgan Stanley opened 161 new positions and closed 377 in Q3 2015.
- Morgan Stanley's portfolio value fell 6.2% quarter-over-quarter to $271B.
Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.